Search the Newsreel

OPKO Health Q2 Earnings Call Highlights

OPKO Health reported a narrower Q2 loss and increased revenue, driven by diagnostics restructuring and a China commercialization agreement. The company ended the quarter with over $300 million in cash and repurchased 9.7 million shares. OPKO also raised its full-year revenue outlook and continues …

OPKO Health (NASDAQ:OPK) Shares Gap Up Following Strong Earnings

OPKO Health (NASDAQ:OPK) saw its shares gap up after reporting better-than-expected quarterly earnings, with a loss of $0.01 per share against an anticipated $0.08 loss and revenue of $163.58 million, exceeding estimates. The company also raised its 2026 revenue outlook and plans to advance …

LPKF Laser & Electronics - Aktie bricht ein -7,62 % - 28.07.2026

OPKO Health (OPK) Stock Jumps As Losses Shrink And Pipeline Progress Builds

OPK Looks 17.0% Overvalued on GF Value™

OPKO Health Inc (OPK) is currently valued as 17.0% overvalued based on GuruFocus's GF Value™ at $1.24 per share against an intrinsic value of $1.06, despite beating Q2 revenue expectations. The company, operating in medical diagnostics and research, shows mixed signals with a GF …

OPKO Health Inc reports results for the quarter ended June 30 - Earnings Summary

OPKO Health Inc has released its financial results for the quarter ended June 30. The article, sourced from Reuters, provides an earnings summary for the company. Readers can access the full report on TradingView.

OPKO HEALTH ($OPK) Releases Q2 2026 Earnings, Stock Rises

OPKO Health: Q2 Earnings Snapshot

This article is an earnings snapshot for OPKO Health's Q2 results. However, the content provided is incomplete and does not contain any financial details or specific information regarding their performance.

OPKO Begins Phase 1 Trials in B-Cell Lymphoma, COVID Prevention

OPKO Health reported Q2 2026 revenues of $163.5 million, an increase from the previous year, with a narrowed net loss. The company highlighted significant progress in its clinical programs, including initiating Phase 1 trials for MDX2003 in B-cell lymphoma and MDX2301 for COVID-19 prevention, …

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results

OPKO Health, Inc. reported its second-quarter 2026 financial results, showcasing significant progress in its clinical pipeline, particularly with ModeX and OPKO Biologics. The company saw an increase in total consolidated revenues to $163.5 million, up from $156.8 million in 2025, and a reduced net …

Park Hotels & Resorts stock hits 52-week high at 15.17 USD

Park Hotels & Resorts Inc. (PK) stock has reached a 52-week high of $15.17, marking a significant upward trend with a 43.26% total return over the past year. This achievement follows strong financial performance, including first-quarter 2026 earnings that surpassed expectations, with an EPS …

Sculptor Capital LP Sells 3,284,153 Shares of Park Hotels & Resorts Inc. $PK

Sculptor Capital LP significantly reduced its stake in Park Hotels & Resorts Inc. by selling over 3.2 million shares, retaining 3.25 million shares valued at approximately $34.2 million. This move comes as Park Hotels reported first-quarter EPS well below expectations, although revenue exceeded forecasts. …

Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics

OPKO Health (OPK) Earnings Date and Reports 2026 $OPK

OPKO Health (NASDAQ:OPK) Issues Earnings Results

OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates

Park Hotels & Resorts (NYSE:PK) Reaches New 12-Month High - Should You Buy?

OPK|OPKO Health Inc|Price:1.370|Chg%:+0.050

MANY PEAKS FPO [MPK] (MPK.AX) Stock Price, News, Quote & History

LPKF Laser Aktie: EBIT rutscht auf minus 14,1 Millionen

Park Hotels & Resorts (NYSE:PK) Stock Rating Upgraded by Wells Fargo & Company

Wells Fargo & Company upgraded Park Hotels & Resorts (NYSE:PK) to a "hold" rating, leading to a mixed analyst consensus of "Reduce" with a target price of $13.18. Despite missing EPS estimates in its last quarter, the company's revenue exceeded expectations, and its stock …

OPKO Health, Inc. Revenue Breakdown – DUS:XCY

This article provides a revenue breakdown for OPKO Health, Inc. (DUS:XCY), detailing its top-performing segments and geographical contributions. In the last year, the company generated €516.73 million, with the Diagnostics segment accounting for €315.26 million, and the United States being the largest contributor with …

LPKF Laser Aktie: LIDE-Markt auf 1,7 Milliarden bis 2030

LPKF Laser Aktie: 16-Prozent-Sturz nach Halbjahresbericht

Park Hotels & Resorts reopens Miami Beach resort after $100M renovation

Park Hotels & Resorts has reopened the Royal Palm South Beach Miami, a Tribute Portfolio Resort, after a $100 million renovation. This extensive upgrade includes 404 guest rooms, a redesigned lobby, new food and beverage concepts, and enhanced meetings spaces, expected to nearly double …

OPKO Health Inc (OPK) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of OPKO Health Inc (OPK), noting its current valuation score of 7.85 within the Healthcare Providers & Services industry. It details the company's financial metrics including a P/E ratio of -4.48 and highlights that other key valuation data …

OPKO Health Sets July 27 Webcast for Results and Guidance

OPKO Health (NASDAQ: OPK) announced it will report its second-quarter 2026 operating and financial results on Monday, July 27, 2026. The company's senior management will host a conference call and webcast at 4:30 p.m. ET to discuss the results, provide a business update, and …

Park Hotels & Resorts Inc. (PK) stock price, news, quote and history

This page provides a detailed financial overview of Park Hotels & Resorts Inc. (PK), a publicly traded lodging real estate investment trust. It includes current stock price and performance data, key financial metrics, recent news, and analyst ratings. The company's portfolio comprises 34 premium-branded …

Here's Why You Should Retain OPK Stock in Your Portfolio for Now

OPKO Health (OPK) is poised for growth due to its BioReference restructuring, 4Kscore sales, digital expansion, and strategic partnerships, including global commercialization of RAYALDEE. While RAYALDEE and a strong pipeline contribute to optimism, the company faces risks from early-stage clinical development, continued operating losses, …

Park Hotels & Resorts completes $100M+ renovation of Royal Palm South Beach Miami

Park Hotels & Resorts Inc. has completed a comprehensive, over $100 million renovation of the Royal Palm South Beach Miami, a Tribute Portfolio Resort. The investment is expected to nearly double the hotel's EBITDA upon stabilization, reflecting Park's strategy of high-return redevelopment projects in …

Miami's Royal Palm Reopens With 404 Rooms, Four New Food Concepts

Park Hotels & Resorts Inc. (NYSE: PK) announced the reopening of the Royal Palm South Beach Miami following a comprehensive $100 million renovation. The project refurbished 404 guestrooms and suites, introduced four new food and beverage concepts, and upgraded public spaces, aiming to double …

OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026

OPKO Health, Inc. will report its second-quarter 2026 financial and operating results on Monday, July 27, 2026. Senior management will host a conference call and webcast at 4:30 p.m. ET to discuss the results, provide a business update, and offer financial guidance. Participants are …

Park reopens overhauled Royal Palm South Beach Miami resort

The article discusses the reopening of the overhauled Royal Palm South Beach Miami Resort by Park Hotels & Resorts. It also includes boilerplate privacy policy information regarding the use of cookies and personal data for analysis, advertising, and content personalization. This privacy information appears …

OPKO Health (OPK) Projected to Announce Earnings on Thursday

OPKO Health (NASDAQ:OPK) is projected to announce its Q2 2026 earnings after market close on Thursday, July 30th. Analysts anticipate an EPS of ($0.08) and revenue of $131.2330 million for the quarter. The company's stock currently has a "Reduce" rating from analysts with an …

Pepkor Plans Flash–Shop2Shop Merger and Future Fintech Listing

How Investors Are Reacting To Park Hotels & Resorts (PK) New Value Rating Amid Cost Pressures

Park Hotels & Resorts (PK) recently received a Zacks Rank #2 and an A grade for Value, drawing investor attention to a potential undervaluation despite rising capital and labor costs. The rating emphasizes the gap between its intrinsic value and market price, though the …